Suppr超能文献

交界性卵巢肿瘤的全球组织学分布:一项系统评价。

Histologic distribution of borderline ovarian tumors worldwide: a systematic review.

机构信息

Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea.

出版信息

J Gynecol Oncol. 2013 Jan;24(1):44-51. doi: 10.3802/jgo.2013.24.1.44. Epub 2013 Jan 8.

Abstract

OBJECTIVE

The histologic types of borderline ovarian tumors (BOTs) exhibit striking differences in clinical behavior and prognosis. Yet, there is no information available on the histologic distribution of BOTs according to geographic region. The purpose of this study was to systematically review this issue worldwide.

METHODS

A comprehensive search of the literature was conducted using electronic databases. Studies were eligible if BOTs were investigated and the histologic distribution of the data was shown. The studies were grouped by geographic region and totaled by country.

RESULTS

Of 487 potentially relevant studies, 51 met our inclusion criteria, as follows: 8 studies from North America (2 countries); 26 studies from Europe (14 countries); 7 studies from the Middle East (3 countries); and 10 studies from East Asia (5 countries). The histologic distribution of BOTs was considerably different in different parts of the world, but follows specific patterns. In general, serous-type BOTs were the predominantly identified histology in North America, the Middle East, and Europe, while mucinous-type BOTs predominated in East Asia.

CONCLUSION

Significant geographic variation is evident among BOT histology in different parts of the world. More research is needed to understand this phenomenon.

摘要

目的

交界性卵巢肿瘤(BOT)的组织学类型在临床行为和预后方面存在显著差异。然而,目前尚无关于 BOT 组织学分布的地理区域信息。本研究的目的是在全球范围内系统地回顾这个问题。

方法

使用电子数据库进行了全面的文献检索。如果研究中调查了 BOT 并显示了数据的组织学分布,则符合纳入标准。研究按地理区域分组,并按国家进行汇总。

结果

在 487 篇潜在相关研究中,有 51 篇符合纳入标准,如下所示:北美(2 个国家)的 8 项研究;欧洲(14 个国家)的 26 项研究;中东(3 个国家)的 7 项研究;东亚(5 个国家)的 10 项研究。BOT 的组织学分布在世界不同地区存在显著差异,但遵循特定模式。一般来说,在北美、中东和欧洲,浆液型 BOT 是主要的组织学类型,而黏液型 BOT 则在东亚占主导地位。

结论

在世界不同地区,BOT 的组织学存在明显的地理差异。需要进一步研究以了解这种现象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed5e/3549507/82ceac1006bf/jgo-24-44-g001.jpg

相似文献

1
Histologic distribution of borderline ovarian tumors worldwide: a systematic review.
J Gynecol Oncol. 2013 Jan;24(1):44-51. doi: 10.3802/jgo.2013.24.1.44. Epub 2013 Jan 8.
2
Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study.
Int J Cancer. 2020 Aug 15;147(4):990-995. doi: 10.1002/ijc.32864. Epub 2020 Jan 21.
3
Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:492-501. doi: 10.1016/j.ejogrb.2020.11.045. Epub 2020 Nov 20.
4
Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.
J Gynecol Obstet Hum Reprod. 2021 Jan;50(1):101965. doi: 10.1016/j.jogoh.2020.101965. Epub 2020 Nov 4.
6
Borderline Ovarian Tumors Share Familial Risks with Themselves and Invasive Cancers.
Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1358-1363. doi: 10.1158/1055-9965.EPI-18-0503. Epub 2018 Jul 17.
7
Prognosis in patients with serous and mucinous stage I borderline ovarian tumors.
Int J Gynecol Cancer. 2012 Jun;22(5):770-7. doi: 10.1097/IGC.0b013e31824b4076.
9
The preoperative diagnosis of borderline ovarian tumors: a review of current literature.
Arch Gynecol Obstet. 2012 Apr;285(4):1103-12. doi: 10.1007/s00404-011-2194-1. Epub 2011 Dec 31.

引用本文的文献

1
The Ultrasonography Characteristics of Borderline Ovarian Tumor Subtypes.
J Ultrasound Med. 2025 Jun 30. doi: 10.1002/jum.16756.
4
Performing Routine Appendectomy in Mucinous Borderline Ovarian Tumours: An Experience of 15 Years From a Cancer Centre.
Cureus. 2024 Jul 28;16(7):e65580. doi: 10.7759/cureus.65580. eCollection 2024 Jul.
5
Borderline tumour recurrence: how quickly does the tumour grow?
BMJ Case Rep. 2024 May 9;17(5):e259501. doi: 10.1136/bcr-2023-259501.
7
Risk of nonovarian cancer in a nationwide-based study of nearly 5000 women with borderline ovarian tumors in Denmark.
Int J Cancer. 2023 Apr 1;152(7):1370-1377. doi: 10.1002/ijc.34354. Epub 2022 Nov 23.
9
Risk factors that increase recurrence in borderline ovarian cancers.
Am J Transl Res. 2021 Jul 15;13(7):8438-8449. eCollection 2021.

本文引用的文献

1
Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
Acta Obstet Gynecol Scand. 2011 Apr;90(4):305-12. doi: 10.1111/j.1600-0412.2010.01060.x. Epub 2011 Feb 18.
3
Risk factors for recurrence of ovarian borderline tumors.
Gynecol Oncol. 2011 Mar;120(3):480-4. doi: 10.1016/j.ygyno.2010.11.016. Epub 2010 Dec 10.
4
Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Arch Gynecol Obstet. 2011 Sep;284(3):731-5. doi: 10.1007/s00404-010-1713-9. Epub 2010 Oct 21.
5
6
Serous and mucinous borderline ovarian tumors: are there real differences between these two entities?
Eur J Obstet Gynecol Reprod Biol. 2010 Dec;153(2):188-92. doi: 10.1016/j.ejogrb.2010.07.024. Epub 2010 Aug 21.
7
Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors?
Arch Gynecol Obstet. 2011 Apr;283(4):879-84. doi: 10.1007/s00404-010-1539-5. Epub 2010 Jun 13.
9
Systematic evaluation of the intraoperative tumor pattern in patients with borderline tumor of the ovary.
Int J Gynecol Cancer. 2009 Dec;19(9):1550-5. doi: 10.1111/IGC.0b013e3181a84699.
10
Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary.
J Gynecol Oncol. 2009 Sep;20(3):176-80. doi: 10.3802/jgo.2009.20.3.176. Epub 2009 Sep 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验